4 research outputs found
Biosynthesis and Reactivity of Cysteine Persulfides in Signaling
Hydrogen
sulfide (H<sub>2</sub>S) elicits pleiotropic physiological
effects ranging from modulation of cardiovascular to CNS functions.
A dominant method for transmission of sulfide-based signals is via
posttranslational modification of reactive cysteine thiols to persulfides.
However, the source of the persulfide donor and whether its relationship
to H<sub>2</sub>S is as a product or precursor is controversial. The
transsulfuration pathway enzymes can synthesize cysteine persulfide
(Cys–SSH) from cystine and H<sub>2</sub>S from cysteine and/or
homocysteine. Recently, Cys–SSH was proposed as the primary
product of the transsulfuration pathway with H<sub>2</sub>S representing
a decomposition product of Cys–SSH. Our detailed kinetic analyses
demonstrate a robust capacity for Cys–SSH production by the
human transsulfuration pathway enzymes, cystathionine beta-synthase
and γ-cystathionase (CSE) and for homocysteine persulfide synthesis
from homocystine by CSE only. However, in the reducing cytoplasmic
milieu where the concentration of reduced thiols is significantly
higher than of disulfides, substrate level regulation favors the synthesis
of H<sub>2</sub>S over persulfides. Mathematical modeling at physiologically
relevant hepatic substrate concentrations predicts that H<sub>2</sub>S rather than Cys–SSH is the primary product of the transsulfuration
enzymes with CSE being the dominant producer. The half-life of the
metastable Cys–SSH product is short and decomposition leads
to a mixture of polysulfides (Cys–S–(S)<sub><i>n</i></sub>–S–Cys). These in vitro data, together
with the intrinsic reactivity of Cys–SSH for cysteinyl versus
sulfur transfer, are consistent with the absence of an observable
increase in protein persulfidation in cells in response to exogenous
cystine and evidence for the formation of polysulfides under these
conditions
Cytochrome <i>c</i> Reduction by H<sub>2</sub>S Potentiates Sulfide Signaling
Hydrogen
sulfide (H<sub>2</sub>S) is an endogenously produced gas that is toxic
at high concentrations. It is eliminated by a dedicated mitochondrial
sulfide oxidation pathway, which connects to the electron transfer
chain at the level of complex III. Direct reduction of cytochrome <i>c</i> (Cyt C) by H<sub>2</sub>S has been reported previously
but not characterized. In this study, we demonstrate that reduction
of ferric Cyt C by H<sub>2</sub>S exhibits hysteretic behavior, which
suggests the involvement of reactive sulfur species in the reduction
process and is consistent with a reaction stoichiometry of 1.5 mol
of Cyt C reduced/mol of H<sub>2</sub>S oxidized. H<sub>2</sub>S increases
O<sub>2</sub> consumption by human cells (HT29 and HepG2) treated
with the complex III inhibitor antimycin A, which is consistent with
the entry of sulfide-derived electrons at the level of complex IV.
Cyt C-dependent H<sub>2</sub>S oxidation stimulated protein persulfidation
in vitro, while silencing of Cyt C expression decreased mitochondrial
protein persulfidation in a cell culture. Cyt C released during apoptosis
was correlated with persulfidation of procaspase 9 and with loss of
its activity. These results reveal a potential role for the electron
transfer chain in general, and Cyt C in particular, for potentiating
sulfide-based signaling
DataSheet_1_Redox integration of signaling and metabolism in a head and neck cancer model of radiation resistance using COSMRO.docx
Redox metabolism is increasingly investigated in cancer as driving regulator of tumor progression, response to therapies and long-term patients’ quality of life. Well-established cancer therapies, such as radiotherapy, either directly impact redox metabolism or have redox-dependent mechanisms of action defining their clinical efficacy. However, the ability to integrate redox information across signaling and metabolic networks to facilitate discovery and broader investigation of redox-regulated pathways in cancer remains a key unmet need limiting the advancement of new cancer therapies. To overcome this challenge, we developed a new constraint-based computational method (COSMro) and applied it to a Head and Neck Squamous Cell Cancer (HNSCC) model of radiation resistance. This novel integrative approach identified enhanced capacity for H2S production in radiation resistant cells and extracted a key relationship between intracellular redox state and cholesterol metabolism; experimental validation of this relationship highlights the importance of redox state in cellular metabolism and response to radiation.</p
DataSheet_2_Redox integration of signaling and metabolism in a head and neck cancer model of radiation resistance using COSMRO.xlsx
Redox metabolism is increasingly investigated in cancer as driving regulator of tumor progression, response to therapies and long-term patients’ quality of life. Well-established cancer therapies, such as radiotherapy, either directly impact redox metabolism or have redox-dependent mechanisms of action defining their clinical efficacy. However, the ability to integrate redox information across signaling and metabolic networks to facilitate discovery and broader investigation of redox-regulated pathways in cancer remains a key unmet need limiting the advancement of new cancer therapies. To overcome this challenge, we developed a new constraint-based computational method (COSMro) and applied it to a Head and Neck Squamous Cell Cancer (HNSCC) model of radiation resistance. This novel integrative approach identified enhanced capacity for H2S production in radiation resistant cells and extracted a key relationship between intracellular redox state and cholesterol metabolism; experimental validation of this relationship highlights the importance of redox state in cellular metabolism and response to radiation.</p